BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22011021)

  • 1. Freckling promoted by topical tacalcitol in a Japanese boy with left eyelid vitiligo.
    Oiso N; Kawada A
    Pediatr Dermatol; 2012; 29(5):671-2. PubMed ID: 22011021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.
    Rodríguez-Martín M; García Bustínduy M; Sáez Rodríguez M; Noda Cabrera A
    Br J Dermatol; 2009 Feb; 160(2):409-14. PubMed ID: 19016706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First case report of topical tacalcitol for vitiligo repigmentation.
    Amano H; Abe M; Ishikawa O
    Pediatr Dermatol; 2008; 25(2):262-4. PubMed ID: 18429797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open trial of topical tacalcitol [1 alpha 24(OH)2D3] and solar irradiation for vitiligo vulgaris: upregulation of c-Kit mRNA by cultured melanocytes.
    Katayama I; Ashida M; Maeda A; Eishi K; Murota H; Bae SJ
    Eur J Dermatol; 2003; 13(4):372-6. PubMed ID: 12948918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo.
    Lu-yan T; Wen-wen F; Lei-hong X; Yi J; Zhi-zhong Z
    Photodermatol Photoimmunol Photomed; 2006 Dec; 22(6):310-4. PubMed ID: 17100739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of clinical efficacy and safety of topical tacalcitol.
    Leone G; Pacifico A
    Acta Biomed; 2005 Apr; 76(1):13-9. PubMed ID: 16116820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
    Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
    Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.
    Lecha M; Mirada A; López S; Artés M;
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of safety and efficacy of topical prostaglandin E2 in treatment of vitiligo.
    Kapoor R; Phiske MM; Jerajani HR
    Br J Dermatol; 2009 Apr; 160(4):861-3. PubMed ID: 19014395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcipotriene and corticosteroid combination therapy for vitiligo.
    Travis LB; Silverberg NB
    Pediatr Dermatol; 2004; 21(4):495-8. PubMed ID: 15283800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacalcitol ointment for the treatment of nail psoriasis.
    Márquez Balbás G; Sánchez Regaña M; Umbert Millet P
    J Dermatolog Treat; 2009; 20(5):308-10. PubMed ID: 19367480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two therapeutic challenges: periocular and genital vitiligo in children successfully treated with pimecrolimus cream.
    Souza Leite RM; Craveiro Leite AA
    Int J Dermatol; 2007 Sep; 46(9):986-9. PubMed ID: 17822508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of a randomized, double-blind, vehicle-controlled study.
    Dawid M; Veensalu M; Grassberger M; Wolff K
    J Dtsch Dermatol Ges; 2006 Nov; 4(11):942-6. PubMed ID: 17081269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pimecrolimus cream in repigmentation of vitiligo.
    Seirafi H; Farnaghi F; Firooz A; Vasheghani-Farahani A; Alirezaie NS; Dowlati Y
    Dermatology; 2007; 214(3):253-9. PubMed ID: 17377388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo.
    Coskun B; Saral Y; Turgut D
    Eur J Dermatol; 2005; 15(2):88-91. PubMed ID: 15757818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute necrotic pancreatitis induced by severe hypercalcaemia due to tacalcitol ointment.
    Knackstedt C; Winograd R; Koch A; Abuzahra F; Trautwein C; Wasmuth HE
    Br J Dermatol; 2007 Mar; 156(3):576-7. PubMed ID: 17300254
    [No Abstract]   [Full Text] [Related]  

  • 17. Topical tacalcitol ointment can be a good therapeutic choice in erythromelanosis follicularis faciei et colli.
    Kim WJ; Song M; Ko HC; Kim BS; Kim MB
    J Am Acad Dermatol; 2012 Aug; 67(2):320-1. PubMed ID: 22794809
    [No Abstract]   [Full Text] [Related]  

  • 18. Eruptive cherry angiomas associated with vitiligo: provoked by topical nitrogen mustard?
    Ma HJ; Zhao G; Shi F; Wang YX
    J Dermatol; 2006 Dec; 33(12):877-9. PubMed ID: 17169094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.
    Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P
    Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion.
    Hartmann A; Bröcker EB; Hamm H
    J Dtsch Dermatol Ges; 2008 May; 6(5):383-5. PubMed ID: 18042249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.